Norcros PLC
F:3N1N
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Norcros PLC
F:3N1N
|
UK |
|
R
|
Rollins Inc
F:RLS
|
US |
|
B
|
Biomarin Pharmaceutical Inc
XMUN:BM8
|
US |
|
P
|
Primo Water Corp
F:GC6
|
US |
|
M
|
Muenchener Rueckversicherungs Gesellschaft in Muenchen AG
OTC:MURGY
|
DE |
Wall St Price Targets
3N1N Price Targets Summary
Norcros PLC
According to Wall Street analysts, the average 1-year price target for 3N1N is 5.19 EUR with a low forecast of 4.28 EUR and a high forecast of 7.47 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 3N1N's stock price target?
Price Target
5.19
EUR
According to Wall Street analysts, the average 1-year price target for 3N1N is 5.19 EUR with a low forecast of 4.28 EUR and a high forecast of 7.47 EUR.
What is the Revenue forecast for Norcros PLC?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 3 years is 8%.
What is the Operating Income forecast for Norcros PLC?
Projected CAGR
18%
Over the last 13 years, the compound annual growth rate for Operating Income has been 8%. The projected CAGR for the next 3 years is 18%.
What is the Net Income forecast for Norcros PLC?
Projected CAGR
122%
Over the last 13 years, the compound annual growth rate for Net Income has been -7%. The projected CAGR for the next 3 years is 122%.
